Mechanisms of the Relaxation Response in Elderly Hypertensives
老年高血压患者松弛反应的机制
基本信息
- 批准号:7392943
- 负责人:
- 金额:$ 16.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAdverse effectsAffectAgeAge-YearsAntihypertensive AgentsAnxietyArousalAttentionAudiotapeBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemClinicalConditionDailyDataDiastolic HypertensionDiastolic blood pressureDiseaseEconomicsElderlyElevationEpinephrineEssential HypertensionEventExhalationFemaleFoundationsFunctional disorderHealth educationHigh Blood PressureHome environmentHormonalHormonesHydrocortisoneImageryIncidenceIndividualInterventionLeftMediationMeditationMind-Body InterventionMyocardial InfarctionNitric OxideNumbersOutcomePatientsPharmaceutical PreparationsPhysiciansPlasmaPopulationPopulations at RiskPrevalenceProductionPulse PressureQi GongRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRandomized Controlled TrialsRelaxationRiskSeveritiesStressStrokeTai JiTestingTherapeuticTimeTrainingTranscendental MeditationVasodilator AgentsWeekWell in selfYogaagedbiological adaptation to stressbody-mindcardiovascular risk factorclinical effectclinically significantcostdeep breathing exerciseshypertension treatmentimprovedindexingpressureresearch studyresponsesystolic hypertensionvolunteeryoung adult
项目摘要
DESCRIPTION (provided by applicant): Systolic Hypertension is a disorder which is characterized by significant elevations in systolic blood pressure in association with normal diastolic blood pressure. Typically, this develops in individuals >50 years of age and is associated with an increased risk of stroke and myocardial infarction. While there are many effective therapies for essential/diastolic hypertension, the treatment of systolic hypertension is complicated by side effects from traditional therapies. This limits therapeutic options and has resulted in a number of at-risk individuals being left untreated. We have recently completed a preliminary study showing that 8-weeks of relaxation response (RR) training significantly reduced systolic blood pressure in individuals with SH. Systolic blood pressure was significantly decreased by 9.4 mmHg and pulse pressure by 7.9 mmHg. This finding would suggest that the RR may be an effective intervention with few to no adverse consequences in this patient population. In other experiments, we found that the RR increased exhaled nitric oxide in young adult volunteers and plasma nitric oxide in female volunteers. Since nitric oxide levels are low in some patients with essential hypertension, abnormalities in nitric oxide availability could be contributing to SH and might be altered by the RR. However, the actual mechanism by which the RR affects SH remains undetermined. Since the RR is known to alter sympathetic responses, this may be one mechanism which explains the effect of the RR on SH. Other mechanisms contributing to this effect could include alteration of vascular function via changes in nitric oxide production or hormonal alterations in sympathetic arousal (i.e., stress response). We hypothesize that the RR reduces systolic blood pressure and pulse pressure without significant side effects and that this occurs by increasing nitric oxide production and/or by reducing stress hormone levels (epinephrine and cortisol). To examine this hypothesis, we propose conducting a randomized, controlled trial (n=90) in which older adults with SH will receive either 8-weeks of RR intervention or Health Education (HE). The primary outcome is change in systolic blood pressure and pulse pressure. Secondary outcomes are changes in nitric oxide, stress hormones and psychological well-being. Additional analyses will be conducted to assess for other confounding effects on BP and PP. Aim 1: Assess if an 8-week RR intervention will decrease systolic blood pressure and pulse pressure compared with HE (control) without significant side effects. Aim 2: Evaluate whether 8-weeks of RR training increases levels of nitric oxide compared with HE. Aim 3: Assess whether 8-weeks of RR training decreases stress hormones (epinephrine and cortisol) and improves psychological well-being (global severity index and anxiety) compared with HE. While elevated systolic blood pressure and pulse pressure are important risk factors for cardiovascular events, concerns about side effects leave many physicians reluctant to treat this condition. Given the challenges of controlling systolic blood pressure pharmacologically and the prevalence of side effects produced by many antihypertensive agents, identification of non-pharmacologic approaches to decrease systolic blood pressure in older Systolic Hypertension (defined as SBP >140 mm Hg with normal diastolic blood pressure (DBP <90 mm Hg) patients could contribute significantly to the treatment of this condition. These positive effects could have significant economic implications by providing a low-cost adjunctive therapy to current pharmacologic approaches and potentially reduce the incidence of cardiovascular events.
描述(由申请人提供):收缩压是一种疾病,其特征是收缩压的显着升高与正常的舒张压相关。通常,这会在50岁以上的个体中发展,并且与中风和心肌梗塞的风险增加有关。虽然有许多有效的疗法用于基本/舒张期高血压,但收缩高压的治疗对传统疗法的副作用变得复杂。这限制了治疗选择,并导致许多处于危险的人未经治疗。我们最近完成了一项初步研究,表明8周的松弛反应(RR)训练显着降低了SH患者的收缩压。收缩压显着降低9.4 mmHg,脉压减少7.9 mmHg。这一发现表明,RR可能是一种有效的干预措施,在该患者人群中几乎没有不利后果。在其他实验中,我们发现在女性志愿者中,RR增加了年轻成人志愿者和血浆一氧化氮的呼出一氧化氮。由于某些基本高血压患者的一氧化氮水平较低,因此一氧化氮的可用性异常可能会导致SH,RR可能会改变。但是,RR影响SH的实际机制仍然不确定。由于RR已知会改变交感反应,因此这可能是一种解释RR对SH的影响的机制。导致这种作用的其他机制可能包括通过一氧化氮产生或交感神经唤醒的激素改变(即应力反应)的变化来改变血管功能。我们假设RR降低了收缩压和脉搏压力而没有明显的副作用,并且通过增加一氧化氮的产生和/或通过降低应激激素水平(肾上腺素和皮质醇)而发生。为了审查这一假设,我们建议进行一项随机,对照试验(n = 90),其中SH的老年人将接受8周的RR干预或健康教育(HE)。主要结果是收缩压和脉压变化。次要结果是一氧化氮,应激激素和心理健康的变化。将进行其他分析以评估对BP和PP的其他混杂作用。 AIM 1:评估与HE(对照)相比,8周的RR干预是否会降低收缩压和脉搏压力,而没有明显的副作用。 AIM 2:评估与HE相比,8周的RR训练是否增加了一氧化氮的水平。 AIM 3:评估8周的RR训练是否减少了压力激素(肾上腺素和皮质醇),并改善与HE相比的心理健康(全球严重程度指数和焦虑)。尽管收缩压和脉压升高是心血管事件的重要危险因素,但对副作用的担忧使许多医生不愿治疗这种情况。鉴于在药理学上控制收缩压的挑战以及许多抗高血压剂产生的副作用的流行,因此鉴定了非药理学方法以降低较旧的收缩压高血压中的收缩压(定义为SBP> 140 mm Hg具有正常的分解性血压<90 mm Hg <90 mM HG)可能会造成这种贡献的情况,这些造成了这些贡献。通过为当前的药理方法提供低成本的辅助疗法,并有可能减少心血管事件的发生率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffery A Dusek其他文献
Mapping Evidence-Based Non-Opioid and Non-Pharmacological Pain Management Modalities Across Minnesota: The Non-Opioid Pain Alleviation Information Network Project.
绘制明尼苏达州循证非阿片类药物和非药理学疼痛管理方式:非阿片类药物疼痛缓解信息网络项目。
- DOI:
10.1089/jicm.2023.0031 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Arti Prasad;Richard Printon;Miamoua Vang;Sophie Kurschner;Jeffery A Dusek - 通讯作者:
Jeffery A Dusek
Impact of SARS-COV-2 (COVID) Infections on Mental Health Diagnoses in Youth With Chronic Illness
SARS-COV-2 (COVID) 感染对慢性病青少年心理健康诊断的影响
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
M. McVoy;Rina Hung;Irina Bransteter;Jaime A. Perez;Tracy L. Segall;Jessica Surdam;David W. Miller;Jeffery A Dusek;Martha Sajatovic - 通讯作者:
Martha Sajatovic
Jeffery A Dusek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffery A Dusek', 18)}}的其他基金
MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS)
MUSIC 疗法解决镰状细胞病生活质量问题的多部位可行性 (MULTI-MUSIQOLS)
- 批准号:
10728452 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
2022 International Congress on Integrative Medicine and Health
2022 年国际中西医结合医学与健康大会
- 批准号:
10468376 - 财政年份:2022
- 资助金额:
$ 16.83万 - 项目类别:
Acupuncture in the Emergency Department for Pain Management: A BraveNet Multi-Center Feasibility Study
急诊科针灸治疗疼痛:BraveNet 多中心可行性研究
- 批准号:
10044074 - 财政年份:2020
- 资助金额:
$ 16.83万 - 项目类别:
Acupuncture in the Emergency Department for Pain Management: A BraveNet Multi-Center Feasibility Study
急诊科针灸治疗疼痛:BraveNet 多中心可行性研究
- 批准号:
10267175 - 财政年份:2020
- 资助金额:
$ 16.83万 - 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients: Admini
补充和替代医学对住院患者疼痛的影响:管理
- 批准号:
8490918 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
- 批准号:
8269882 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
- 批准号:
8075342 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
- 批准号:
8496497 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
- 批准号:
8668904 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Mechanisms of the Relaxation Response in Elderly Hypertensives
老年高血压患者松弛反应的机制
- 批准号:
7686903 - 财政年份:2008
- 资助金额:
$ 16.83万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
- 批准号:
10822651 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别: